Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Green and Sustainable Bioprocessing Technologies Market - Strategic Insights and Forecasts (2026-2031) | 11.5% CAGR Creates a USD 13.6 Billion Opportunity

globenewswire.com

Global Green and Sustainable Bioprocessing Technologies Market - Strategic Insights and Forecasts (2026-2031) | 11.5% CAGR Creates a USD 13.6 Billion Opportunity Dublin, Oct. 01, 2026 (GLOBE NEWSWIRE) -- "Green and Sustainable Bioprocessing Technologies Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.

The global green and sustainable bioprocessing technologies market is projected to grow from USD 7.9 billion in 2026 to USD 13.6 billion by 2031, representing a CAGR of 11.5%. Growth is being supported by the transition toward low-carbon manufacturing, circular bioeconomy models, and environmentally responsible production across the biopharmaceutical and industrial biotechnology sectors.

Demand for biologics, bio-based chemicals, sustainable materials, and advanced therapies is encouraging manufacturers to integrate eco-efficient technologies throughout upstream and downstream operations. Companies are investing in resource optimization, energy efficiency, water conservation, and waste reduction to meet corporate sustainability targets and comply with evolving environmental regulations.

Key Green and Sustainable Bioprocessing Market Drivers

Environmental sustainability has become a strategic priority for biopharmaceutical manufacturers seeking to reduce carbon emissions, chemical waste, and water consumption. Stricter environmental policies and global decarbonization commitments are accelerating the adoption of cleaner manufacturing platforms.

The continued expansion of monoclonal antibodies, vaccines, and cell and gene therapies is also creating demand for scalable bioprocessing technologies. Single-use systems, continuous processing, and perfusion-based platforms can improve production efficiency, reduce cleaning requirements, limit contamination risks, and support more effective resource management.

Innovation in biodegradable materials, renewable feedstocks, process optimization, automation, artificial intelligence, and digital monitoring is further strengthening market growth. Real-time process control allows manufacturers to improve consistency, identify inefficiencies, and reduce unnecessary resource consumption. Circular economy initiatives are also encouraging greater reuse, recovery, and recycling of materials across bioprocessing workflows.

Market Challenges

High initial investment remains a significant barrier to adoption. Green and sustainable bioprocessing technologies may require advanced equipment, specialized materials, facility upgrades, and extensive process redesign. These requirements can increase capital expenditure, particularly for smaller biotechnology companies and manufacturers operating with established infrastructure.

Technical complexity also affects implementation. Sustainable systems must be integrated across upstream and downstream operations without compromising product quality, scalability, consistency, or regulatory compliance. Regional differences in environmental and manufacturing requirements can create additional challenges for global organizations. The limited availability of standardized sustainable materials and platforms may also restrict adoption in certain applications.

Technology and Segment Insights

The market is analyzed by product, process type, application, and end user. Single-use systems represent a leading product category because of their operational flexibility, lower cleaning requirements, reduced contamination risk, and potential to decrease water and energy consumption.

Batch processing maintains a substantial market share due to its established role in biomanufacturing. However, continuous processing and perfusion-based systems are expected to record faster growth. These technologies can increase productivity, reduce downtime, optimize facility utilization, and minimize resource use.

Biopharmaceutical manufacturing is the largest application segment, supported by rising demand for biologics and advanced therapies. Industrial biotechnology is also gaining momentum as manufacturers expand the sustainable production of biofuels, enzymes, specialty chemicals, and other bio-based products.

Major end users include pharmaceutical companies, biotechnology firms, and contract manufacturing organizations. Biopharmaceutical companies account for a significant share as they increase investments in sustainable production, manufacturing capacity, and regulatory compliance.

Competitive and Strategic Outlook

Competition is intensifying as technology providers, biopharmaceutical manufacturers, contract manufacturing organizations, and research institutions collaborate on eco-efficient production platforms. Research and development investments are focused on biodegradable materials, energy-efficient equipment, renewable inputs, digital process control, and scalable manufacturing systems.

Partnerships, acquisitions, and portfolio expansion are helping market participants strengthen technical capabilities and address changing customer requirements. Emerging markets are expected to provide additional opportunities as biotechnology investment and sustainable manufacturing infrastructure continue to expand.

Key Benefits of the Report

Business Applications

Organizations can use the report for opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, partnership planning, and competitive intelligence.

Report Coverage

The green and sustainable bioprocessing technologies market is positioned for sustained expansion as manufacturers pursue cleaner, more efficient production. Although investment requirements, technical integration, and regulatory differences may affect implementation, continued innovation and broader industry adoption are expected to support long-term market growth.

Key Topics Covered:

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

3.4. Porter's Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations

3.7. Strategic Recommendations

3.8. Product Pipeline Analysis

3.9. Incidence and Prevalence Analysis

3.10. Patent Analysis

4. TECHNOLOGICAL OUTLOOK

5. GREEN AND SUSTAINABLE BIOPROCESSING TECHNOLOGIES MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Single-Use Systems

5.3. Continuous Bioprocessing Technologies

5.4. Filtration & Separation Technologies

5.5. Chromatography Systems

5.6. Bioreactors

5.7. Purification & Downstream Processing

5.8. Digital & Automation Solutions

5.9. Sustainable Consumables and Materials

6. GREEN AND SUSTAINABLE BIOPROCESSING TECHNOLOGIES MARKET BY TECHNOLOGY

6.1. Introduction

6.2. Upstream Processing Technologies

6.3. Downstream Processing Technologies

6.4. Process Analytical Technologies (PAT)

6.5. Smart Manufacturing / Digital Twin Platforms

6.6. Lifecycle Assessment & Sustainability Tools

7. GREEN AND SUSTAINABLE BIOPROCESSING TECHNOLOGIES MARKET BY END-USER

7.1. Introduction

7.2. Biopharmaceutical Companies

7.3. Pharmaceutical Manufacturers

7.4. Contract Development and Manufacturing Organizations (CDMOs)

7.5. Biotechnology Firms

7.6. Research Institutions & CROs (Contract Research Organizations)

8. GREEN AND SUSTAINABLE BIOPROCESSING TECHNOLOGIES MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Sartorius AG

10.2. Thermo Fisher Scientific Inc.

10.3. Danaher Corporation

10.4. Cytiva

10.5. Pall Life Sciences

10.6. Lonza Group AG

10.7. Corning Inc.

10.8. Eppendorf AG

10.9. Avantor Inc.

10.10. Repligen Corporation

11. APPENDIX

11.1. Currency

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key Benefits for the Stakeholders

11.5. Research Methodology

11.6. Abbreviations

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/c4ythq

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.